This inventor holds 1 USPTO granted patent. Top assignee: China Medical University. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Innovations of Chin-Heng Yang in Polysaccharide Nanocomposite Particles
Introduction
Chin-Heng Yang is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of materials science, particularly in the development of polysaccharide nanocomposite particles. His innovative methods have potential applications in various industries, including medicine and biotechnology.
Latest Patents
Chin-Heng Yang holds a patent titled "Method for preparing polysaccharide nanocomposite particles and uses of the same." This patent describes a method that involves providing a first solution containing an active component and a polysaccharide. A cross-linking agent is then added to this solution, resulting in a second solution that undergoes a reaction to form polysaccharide nanocomposite particles. The particles produced exhibit a good coating ratio and enhanced applicability. Additionally, the patent outlines a method for inducing cancer cell apoptosis in a subject by administering an effective amount of these polysaccharide nanocomposite particles.
Career Highlights
Chin-Heng Yang is affiliated with China Medical University, where he continues to engage in research and development. His work focuses on innovative solutions that leverage the unique properties of polysaccharides in nanotechnology.
Collaborations
Chin-Heng Yang has collaborated with esteemed colleagues such as Yueh-Hsiung Kuo and Chih-Wei Chou. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
Chin-Heng Yang's contributions to the field of polysaccharide nanocomposite particles exemplify the intersection of innovation and practical application. His work not only advances scientific knowledge but also holds promise for future medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
